AdComSep 03, 2026
FDA advisory — Here Are Thursday’s Top Wall Street Analyst Research Calls: Broadcom, Deere & Company, Dell Technologies, Devon Energy,…▸
high impact
Data +Sep 03, 2026
Positive data — This Fund Bought Moderna Before It Nearly Tripled. See Its 2 New Stock Picks▸
high impact
Data +Sep 02, 2026
Positive data — Did Merck’s (MRK) First Positive Phase 3 Individualized mRNA Cancer Trial Just Redefine Its Moat?▸
high impact
ApprovalSep 01, 2026
FDA approval — GSK hopes to take on Moderna as it moves mRNA flu vaccine to Phase III trial▸
high impact
Data +Aug 30, 2026
Positive data — Merck (MRK) Posts First Positive Phase 3 Result For Personalized mRNA Melanoma Therapy▸
high impact
DealAug 25, 2026
Deal — Nayax, Immatics, Moderna, Marvell Technology And Other Big Stocks Moving Higher On Tuesday▸
medium impact
Data +Aug 20, 2026
Positive data — Why Is Tempus AI Stock Gaining Thursday?▸
high impact
EarningsJul 31, 2026
Q2 2026 report+2.6%muted
EarningsMay 01, 2026
Q1 2026 report+7.5%positive
EarningsFeb 13, 2026
FY 2025 report+17.7%positive
EarningsJan 12, 2026
FY 2025 report+16.3%positive
EarningsNov 06, 2025
Q3 2025 report+8.5%positive
EarningsAug 01, 2025
Q2 2025 report-3.2%negative
Data +Jul 10, 2025
mRNA-4157 Phase 3 interim (melanoma)▸
high impact
EarningsMay 01, 2025
Q1 2025 report-9.6%negative
EarningsFeb 14, 2025
FY 2024 report+2.2%muted
EarningsJan 13, 2025
FY 2024 report-4.0%negative
EarningsNov 07, 2024
Q3 2024 report-13.5%negative
Data +Sep 10, 2024
mRNA-4157 Phase 2b melanoma 3-year follow-up▸
high impact